Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | F3 | P13726 | 3/20 | 1.00 |
| ▸ | XDH | P47989 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | P4HB | P07237 | 1/20 | 1.00 |
| ▸ | CALM1 | P0DP23 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 9/20 | 0.77 |
| ▸ | MAOA | P21397 | 3/20 | 0.77 |
| ▸ | NPC1 | O15118 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.74 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.74 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.74 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.74 |
| ▸ | BCHE | P06276 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25194802 | 1.00 | MAPT (1.00) | MAPTF3XDHMEN1ALDH1A1 | |
| SCHEMBL3889363 | 1.00 | MAPT (1.00) | MAPTF3XDHMEN1ALDH1A1 | |
| SCHEMBL3889361 | 1.00 | MAPT (1.00) | MAPTF3XDHMEN1ALDH1A1 | |
| SCHEMBL25189143 | 1.00 | MAPT (1.00) | MAPTF3XDHMEN1ALDH1A1 | |
| SCHEMBL145788 | 1.00 | MAPT (1.00) | MAPTF3XDHMEN1ALDH1A1 | |
| 4,4'-Dimethoxychalcone SCHEMBL978243 | 0.93 | F3 (1.00) | MAPTF3XDHMEN1ALDH1A1 | |
| 4,4'-Dimethoxychalcone SCHEMBL978242 | 0.93 | F3 (1.00) | MAPTF3XDHMEN1ALDH1A1 | |
| SCHEMBL25199635 | 0.88 | F3 (0.78) | MAPTF3XDHMEN1ALDH1A1 | |
| SCHEMBL25221620 | 0.88 | F3 (0.78) | MAPTF3XDHMEN1ALDH1A1 | |
| SCHEMBL11471612 | 0.88 | MAPT (0.78) | MAPTF3XDHMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20260013312-A1 | PHOTOSENSITIVE ORGANIC INSULATING MATERIAL COMPOSITION, INSULATING FILM, GATE INSULATING FILM, TRANSISTOR, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSISTOR | NIKON CORPORATION (JP) | 2026-01-08 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| CN-119954731-A | Chalcone derivative containing 4-quinazolinone structure, and preparation method and application thereof | 黔南州烟草公司平塘县分公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2025069235-A1 | COMPOUND, PHOTOSENSITIVE SURFACE TREATMENT AGENT, LAMINATE PRODUCTION METHOD, AND TRANSISTOR PRODUCTION METHOD | 株式会社ニコン | 2025-04-03 | — | — | WO | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| WO-2024189876-A1 | PHOTOSENSITIVE ORGANIC INSULATING MATERIAL COMPOSITION, INSULATING FILM, GATE INSULATING FILM, TRANSISTOR, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSISTOR | 株式会社ニコン | 2024-09-19 | — | — | WO | disclosed |
| WO-2024189875-A1 | PHOTOSENSITIVE ORGANIC INSULATING MATERIAL COMPOSITION, INSULATING FILM, GATE INSULATING FILM, TRANSISTOR, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSISTOR | 株式会社ニコン | 2024-09-19 | — | — | WO | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| US-20100093955-A1 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2010-04-15 | — | — | US | disclosed |
| US-20090181324-A1 | PHOTOSENSITIVE POLYIMIDES | ETERNAL CHEMICAL CO., LTD. | 2009-07-16 | — | — | US | disclosed |
| WO-2008115028-A1 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2008-09-25 | — | — | WO | disclosed |
| US-20070128658-A1 | FLUORESCENT DYES, METHODS AND USES THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2007-06-07 | — | — | US | disclosed |
| US-20060142303-A1 | Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents | PRATAP RAM | 2006-06-29 | — | — | US | disclosed |
| US-20030104145-A1 | Chemical adsorbent and liquid crystal alignment layer utilizing the same and liquid crystal display device utilizing the same and methods of manufacturing them | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2003-06-05 | — | — | US | disclosed |
| US-6495221-B1 | EXTREMELY THIN AND TRANSPARENT FILM IN NANOMETER ORDER; HYDROCHALCONE DERIVATIVE SUBSTITUTED WITH A ISOCYANATOSILYL GROUP | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-0962460-A1 | CHEMISORPTIVE SUBSTANCE, ALIGNED LIQUID-CRYSTAL FILM AND LIQUID-CRYSTAL DISPLAY ELEMENT BOTH MADE BY USING THE SAME, AND PROCESSES FOR PRODUCING THESE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1999-12-08 | — | — | EP | disclosed |
| US-5525457-A | Copolymers of unsaturated carboxylic acid, an epoxy-functional monomer, and cinnamoylphenyl group-monomer; high halation preventing effect, involves no sublimation of radiation absorbing components contained therein, possesses excellent heat resistance, dry etching performance, storage stability | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1996-06-11 | — | — | US | disclosed |
| US-4584190-A | AROMATIC, UNSATURATED, OXO, OXYESTER | KAO CORPORATION (JP) | 1986-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030104145-A1 | Chemical adsorbent and liquid crystal alignment layer utilizing the same and liquid crystal display device utilizing the same and methods of manufacturing them | UACA, CRYAA, CUTA | MAPT 46/4885F3 876/4885XDH 510/4885 |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAPT 3297/4885F3 5/4885XDH 1328/4885 |
| US-20260013312-A1 | PHOTOSENSITIVE ORGANIC INSULATING MATERIAL COMPOSITION, INSULATING FILM, GATE INSULATING FILM, TRANSISTOR, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSISTOR | ICMT, PIGT, PORCN | MAPT 340/4885F3 783/4885XDH 3965/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885F3 11/4885XDH 1963/4885 |
| US-20060142303-A1 | Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents | LIPC, CYP46A1, HMGCR | MAPT 4801/4885F3 1338/4885XDH 1425/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885F3 11/4885XDH 1963/4885 |
| US-20100093955-A1 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | PCNA, LCP1, CCND2 | MAPT 103/4885F3 2050/4885XDH 4171/4885 |
| US-20070128658-A1 | FLUORESCENT DYES, METHODS AND USES THEREOF | DHX15, DHX35, DUT | MAPT 3454/4885F3 2344/4885XDH 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.